NEW DATA SHOWS SYNEXIS® DHP™ TECHNOLOGY SIGNIFICANTLY REDUCES HOSPITAL-ACQUIRED INFECTION RATES
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Oxbryta® Tablets for Oral Suspension, A New Dispersible Tablet Dosage Form, Now Available for Patients with Sickle Cell Disease in the United States SOUTH SAN FRANCISCO,... | January 10, 2022
/PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent imaging agents to target and illuminate cancer...
/PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent imaging agents to target and illuminate cancer...
/CNW/ - Novo Nordisk announced today that Health Canada has approved Wegovy™ (semaglutide injection), the first-and-only prescription weight-loss medication...